🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Elisabetta Marangoni

Université Paris Sciences et Lettres

ORCID: 0000-0002-3337-6448

Also affiliated with Institut Curie

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach”.

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach

iScience(2022)10.1016/j.isci.2022.105799

N/A

0.830DataRank · unranked

35 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram Srinivasan +25 more

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Nature Genetics(2021)10.1038/s41588-020-00750-6

N/A

0.790DataRank · unranked

193 citations

Jessica Giordano, Anuj Srivastava, Min Jin Ha, Michael W. Lloyd, Roebi de Bruijn +57 more

Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance

Nature Cell Biology(2020)10.1038/s41556-020-0514-z

N/A

0.741DataRank · unranked

139 citations

Zhao Zhang, Yi‐Zhou Jiang, Pengya Xue, Hu Wang, Zhao Lai +16 more

A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.20.457116

N/A

0DataRank · unranked

5 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram +19 more

Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis

Cell Reports(2022)10.1016/j.celrep.2022.111742

N/A

0DataRank · unranked

29 citations

Mohamed Faisal Kassir, Firdevs Cansu Atilgan, Han Gyul Lee, Megan A. Sheridan, Natalia V. Oleinik +14 more

Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

Nature Communications(2023)10.1038/s41467-023-42736-y

N/A

0DataRank · unranked

13 citations

Metin Çetįn, Meral Üner, Ünal Metin Tokat, Ioulia Chatzistamou, Pelin G. Ersan +8 more

Liver X receptors induce antiproliferative effects in basal‐like breast cancer

Molecular Oncology(2023)10.1002/1878-0261.13476

N/A

0DataRank · unranked

3 citations

Hedda von der Lippe Gythfeldt, Eivind Valen Egeland, Lisa Svartdal Normann, Abhilash Pandya, Lise‐Lotte Vedin +10 more

Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models

Drug Resistance Updates(2024)10.1016/j.drup.2024.101078

N/A

0DataRank · unranked

16 citations

Arup Bhattacharya, Darrell L. Peterson, Yun Li, Xiaozhuo Liu, Elisabetta Marangoni +3 more

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

Science Translational Medicine(2020)10.1126/scitranslmed.aax2625

N/A

0DataRank · unranked

148 citations

Rania El Botty, Sophie Château‐Joubert, Ahmed Dahmani, Élodie Montaudon, Sophie Leboucher +29 more

Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0435

N/A

0DataRank · unranked

7 citations

Elisabetta Marangoni, Fathi Elloumi, Rémi Montagne, Sudhir Varma, Yanghsin Wang +11 more

Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancers

UNC Libraries(2020)10.17615/ymkd-4394

N/A

0DataRank · unranked

0 citations

Whitney S. Henry, Laetitia Fuhrmann, Alex Toker, Cheng Fan, Antoine E. Karnoub +9 more

The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer

JCI Insight(2021)10.1172/jci.insight.147617

N/A

0DataRank · unranked

42 citations

Shayna Stein, Otto Metzger, Jennifer Eng, Natalie L. Kingston, Nicholas W. Harper +18 more